• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童和青少年滤泡状甲状腺癌:临床病理特征、长期生存和复发的危险因素。

Follicular thyroid cancer in children and adolescents: clinicopathologic features, long-term survival, and risk factors for recurrence.

机构信息

Noguchi Thyroid Clinic and Hospital Foundation, Beppu, Oita 874-0932, Japan.

出版信息

Endocr J. 2013;60(5):629-35. doi: 10.1507/endocrj.ej12-0372. Epub 2013 Jan 17.

DOI:10.1507/endocrj.ej12-0372
PMID:23327804
Abstract

Children and adolescents represent 1-1.5% of all patients with thyroid cancer (TC). The vast majority of TC in children and adolescents is papillary TC; follicular TC (FTC) is exceedingly rare. In this study, we evaluate the clinical and pathological features of FTC in children and adolescents. We also report the risk factors for post-operative tumor recurrence and the associated outcomes. Twenty children and adolescents (under 21 years old) with FTC have been treated and followed at Noguchi Thyroid Clinic and Hospital Foundation since 1946. All patients underwent surgery (lobectomy, 11; subtotal thyroidectomy, 8; and total thyroidectomy, 1), and 8 patients received postoperative external beam radiation therapy. The incidence of FTC in children and adolescents was 1.9% among all FTC patients treated in our hospital. Histopathology revealed vascular and capsular invasion in 9 and 20 patients, respectively. The tumor recurrence rate in FTC with vascular invasion is significantly higher than in those without it (p = 0.038). No other factors were significant. Patients with recurrences were treated with completion thyroidectomy and ¹³¹I radioactive iodine therapy. There were no significant differences in the rates of disease-free survival or cause-specific survival when pediatric/adolescent FTC patients were compared to adults with FTC. FTC is very rare among children and adolescents, but the outcomes are similar to those observed among adults. Vascular invasion is poor prognostic indicator in pediatric/adolescent FTC patients.

摘要

儿童和青少年占所有甲状腺癌 (TC) 患者的 1-1.5%。儿童和青少年中绝大多数 TC 为乳头状 TC;滤泡性 TC (FTC) 极为罕见。在这项研究中,我们评估了儿童和青少年 FTC 的临床和病理特征。我们还报告了术后肿瘤复发的危险因素及其相关结果。自 1946 年以来,Noguchi 甲状腺诊所和医院基金会治疗并随访了 20 名患有 FTC 的儿童和青少年(年龄在 21 岁以下)。所有患者均接受手术治疗(11 例接受 lobectomy,8 例接受 subtotal thyroidectomy,1 例接受 total thyroidectomy),8 例患者接受术后外照射放疗。在我院治疗的所有 FTC 患者中,FTC 患儿的发病率为 1.9%。组织病理学显示,9 例和 20 例患者分别有血管和包膜侵犯。有血管侵犯的 FTC 肿瘤复发率明显高于无血管侵犯者(p = 0.038)。其他因素无显著差异。有复发的患者接受了 completion thyroidectomy 和 ¹³¹I 放射性碘治疗。与 FTC 成人患者相比,儿科/青少年 FTC 患者的无病生存率或特定病因生存率无显著差异。FTC 在儿童和青少年中非常罕见,但结果与成人观察到的相似。血管侵犯是儿科/青少年 FTC 患者预后不良的指标。

相似文献

1
Follicular thyroid cancer in children and adolescents: clinicopathologic features, long-term survival, and risk factors for recurrence.儿童和青少年滤泡状甲状腺癌:临床病理特征、长期生存和复发的危险因素。
Endocr J. 2013;60(5):629-35. doi: 10.1507/endocrj.ej12-0372. Epub 2013 Jan 17.
2
Prognostic factors of minimally invasive follicular thyroid carcinoma: extensive vascular invasion significantly affects patient prognosis.微创滤泡状甲状腺癌的预后因素:广泛血管侵犯显著影响患者预后。
Endocr J. 2013;60(5):637-42. doi: 10.1507/endocrj.ej12-0419. Epub 2013 Jan 18.
3
Minimally invasive follicular thyroid carcinomas: prognostic factors.微小浸润性滤泡状甲状腺癌:预后因素
Endocrine. 2016 Aug;53(2):505-11. doi: 10.1007/s12020-016-0876-y. Epub 2016 Feb 8.
4
Minimally invasive follicular thyroid cancer: treat as a benign or malignant lesion?微创性滤泡状甲状腺癌:应视为良性还是恶性病变?
J Surg Res. 2017 Jan;207:235-240. doi: 10.1016/j.jss.2016.08.052. Epub 2016 Aug 20.
5
Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.乳头状和滤泡状甲状腺癌的病理肿瘤-淋巴结-转移(pTNM)分期:700例患者的回顾性分析
J Clin Endocrinol Metab. 1997 Nov;82(11):3553-62. doi: 10.1210/jcem.82.11.4373.
6
Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.乳头状和滤泡状甲状腺癌的预后因素:它们对癌症分期的影响。
Ann Surg Oncol. 2007 Feb;14(2):730-8. doi: 10.1245/s10434-006-9207-5. Epub 2006 Nov 11.
7
Randomised comparison of 1.1 GBq and 3.7 GBq radioiodine to ablate the thyroid in the treatment of low-risk thyroid cancer: a 13-year follow-up.随机比较 1.1GBq 和 3.7GBq 放射性碘消融治疗低危甲状腺癌:13 年随访。
Acta Oncol. 2020 Sep;59(9):1064-1071. doi: 10.1080/0284186X.2020.1785003. Epub 2020 Jun 30.
8
Prognostic factors of follicular thyroid carcinoma.滤泡状甲状腺癌的预后因素。
Endocrinol Nutr. 2015 Jan;62(1):11-8. doi: 10.1016/j.endonu.2014.06.006. Epub 2014 Aug 22.
9
[Draft of the best medical treatment in patients with low-risk thyroid cancer].[低风险甲状腺癌患者最佳医学治疗方案草案]
Vnitr Lek. 2015 Sep;61(9):769-77.
10
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.初始手术和药物治疗对乳头状和滤泡状甲状腺癌的长期影响。
Am J Med. 1994 Nov;97(5):418-28. doi: 10.1016/0002-9343(94)90321-2.

引用本文的文献

1
The Initial Risk Stratification System for Differentiated Thyroid Cancer: Key Updates in the 2024 Korean Thyroid Association Guideline.分化型甲状腺癌的初始风险分层系统:2024年韩国甲状腺协会指南的关键更新
Endocrinol Metab (Seoul). 2025 Jun;40(3):357-384. doi: 10.3803/EnM.2025.2465. Epub 2025 Jun 24.
2
Management of Thyroid Nodules in Children: A single-center experience.儿童甲状腺结节的管理:单中心经验
Iran J Otorhinolaryngol. 2025;37(2):65-71. doi: 10.22038/ijorl.2024.78964.3659.
3
Long-term oncological outcomes of follicular thyroid cancer in adolescents and young adults: A nationwide population-based study.青少年和年轻成年人滤泡性甲状腺癌的长期肿瘤学结局:一项基于全国人群的研究。
World J Surg. 2025 Jan;49(1):98-105. doi: 10.1002/wjs.12279. Epub 2024 Jul 7.
4
Thyroid nodules in children and adolescents: Investigation and management.儿童和青少年甲状腺结节:检查与处理。
J Paediatr Child Health. 2022 Dec;58(12):2163-2168. doi: 10.1111/jpc.16257. Epub 2022 Nov 16.
5
2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma.2022年欧洲甲状腺协会儿童甲状腺结节和分化型甲状腺癌管理指南。
Eur Thyroid J. 2022 Nov 29;11(6). doi: 10.1530/ETJ-22-0146. Print 2022 Dec 1.
6
Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline.儿科分化型甲状腺癌:英国国家临床实践共识指南。
Endocr Relat Cancer. 2022 Sep 7;29(11):G1-G33. doi: 10.1530/ERC-22-0035. Print 2022 Nov 1.
7
Long-Term Oncological Outcomes of Papillary Thyroid Cancer and Follicular Thyroid Cancer in Children: A Nationwide Population-Based Study.儿童甲状腺乳头状癌和滤泡状甲状腺癌的长期肿瘤学结局:一项全国范围内基于人群的研究。
Front Endocrinol (Lausanne). 2022 May 4;13:899506. doi: 10.3389/fendo.2022.899506. eCollection 2022.
8
Synergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical Models.乐伐替尼(E7080)与MEK抑制剂对临床前模型中未分化甲状腺癌的协同作用
Cancers (Basel). 2021 Feb 18;13(4):862. doi: 10.3390/cancers13040862.
9
Distant Metastases From Childhood Differentiated Thyroid Carcinoma: Clinical Course and Mutational Landscape.儿童期分化型甲状腺癌的远处转移:临床过程和突变特征。
J Clin Endocrinol Metab. 2021 Mar 25;106(4):e1683-e1697. doi: 10.1210/clinem/dgaa935.
10
A novel therapeutic approach for anaplastic thyroid cancer through inhibition of LAT1.通过抑制 LAT1 为间变性甲状腺癌提供一种新的治疗方法。
Sci Rep. 2019 Oct 10;9(1):14616. doi: 10.1038/s41598-019-51144-6.